Matthieu Frechin

Last updated on 2014-04-25T11:48+0300.

About this image

sign

Quotes... Extracted quotes from

Matthieu Frechin said : "The current worldwide health crisis is an exceptional and unprecedented situation from all points of view. After a strong first quarter driven by the measures we adopted to ensure continued supply of our drugs to the market, we expect sales to fall in the second quarter, especially in the companion animal segment. Meanwhile, our teams will continue to prepare to integrate the Drontal and Profender product ranges in the second half of 2020. Throughout this crisis, our laboratory has remained operational so that we can continue to fulfill our public health duty by providing care for livestock and pets. As far as resources permit, we have managed to provide masks, overalls and hydroalcoholic gel to medical establishments located near our production facilities. This continuity of care embodies the contribution made by our Company to face the challenges of the Covid-19 pandemic" External link

finanznachrichten-en Thursday, April 16, 2020 8:22:00 PM EAT

Matthieu Frechin said : “2019 featured growth in our Essentials products throughout our strategic regions and our Brazilian acquisition opened the door for us to build a big presence in the world’s third largest animal health market. We also made great strides in R&D that included launching or extending new products. That said, we took on board non-recurring costs that hit our bottom line. Our February 2020 announcement that we will acquire* a leading parasiticide product family opens up new opportunities. Lastly, regarding the current health crisis, I would like to salute the great work of our people who have all met their public health and ongoing care duties” External link

4-traders Thursday, March 26, 2020 10:54:00 AM EAT

Matthieu Frechin said : "We achieved a solid second semester and our annual performance is the result of our focused strategy and the acquisition in Brazil. This is reflected in the continued growth in Essentials sales across all strategic territories. The integration of Clarion in Brazil is progressing according to plan, while we continue to work on reorganizing our production facilities in Europe. We therefore look forward to 2020 with confidence in our plans to invest and secure sustainable long-term growth for our Group" External link

finanznachrichten-en Thursday, January 23, 2020 8:04:00 PM EAT

Matthieu Frechin déclaré : "Nous demeurons confiants pour la fin de l'exercice 2019 et restons actifs dans l'étude de dossiers de croissance externe" External link

capital-FR Thursday, October 17, 2019 5:41:00 PM EAT

Matthieu Frechin déclaré : "Nous demeurons confiants pour la fin de l'exercice 2019 et restons actifs dans l'étude de dossiers de croissance externe" External link

capital-FR Wednesday, October 16, 2019 7:28:00 PM EAT

Matthieu Frechin said : "We are delighted to have signed this agreement, which is fully in line with our In Motion strategic plan. Brazil is the third largest animal health market in the world and this acquisition will help further our plans to strengthen our foothold on this market" External link

finanznachrichten-en Thursday, April 4, 2019 9:23:00 AM EAT

Matthieu Frechin said : “We are delighted to have signed this agreement, which is fully in line with our In Motion strategic plan. Brazil is the third largest animal health market in the world and this acquisition will help further our plans to strengthen our foothold on this market” External link

4-traders Thursday, April 4, 2019 9:19:00 AM EAT

Matthieu Frechin said : “We are delighted to have signed this agreement, which is fully in line with our In Motion strategic plan. Brazil is the third largest animal health market in the world and this acquisition will help further our plans to strengthen our foothold on this market” External link

businesswire Thursday, April 4, 2019 9:11:00 AM EAT

Matthieu Frechin said : "This initial agreement demonstrates our commitment to the biotechnology sector. This investment is in keeping with our innovation strategy aimed at providing our vet customers with solutions for diseases where treatment is still lacking. PAT's ground-breaking technology can be adapted to the animal health sector, particularly in the area of monoclonal antibodies. PAT works on molecules of natural origin that are a potential alternative source of active ingredients for our future drugs" External link

finanznachrichten-en Monday, November 13, 2017 10:19:00 PM EAT



Key Titles and Phrases Count Lang Last Seen
directeur général70.00%FR01/26/201726/01/2017
ceo20.00%EN10/18/201618/10/2016
vétoquinol group ceo10.00%EN12/16/201316/12/2013
Names Lang Count
Matthieu FrechinFR66.67%
Matthieu FrechinEN33.33%


 
Show/hide duplicate news articles.
<<10<12345678910>>>10
 
Show/hide duplicate news articles.
<<10<12345678910>>>10

Tools

Load latest edition

Thursday, June 4, 2020

1:42:00 PM EAT

Languages Collapse menu...Expand menu...

Select your languages

af
am
ar
de
en
es
fr
ha
pt
rw
sw
all
Show additional languagesHide additional languages

Interface:

Legend Collapse menu...Expand menu...


Quotes... Explore Relations


EMM Visual Explorer


AfricaBrief

Matthieu Frechin

Last updated on 2014-04-25T11:48+0300.

About this image

sign

Quotes... Extracted quotes from

Matthieu Frechin said : "The current worldwide health crisis is an exceptional and unprecedented situation from all points of view. After a strong first quarter driven by the measures we adopted to ensure continued supply of our drugs to the market, we expect sales to fall in the second quarter, especially in the companion animal segment. Meanwhile, our teams will continue to prepare to integrate the Drontal and Profender product ranges in the second half of 2020. Throughout this crisis, our laboratory has remained operational so that we can continue to fulfill our public health duty by providing care for livestock and pets. As far as resources permit, we have managed to provide masks, overalls and hydroalcoholic gel to medical establishments located near our production facilities. This continuity of care embodies the contribution made by our Company to face the challenges of the Covid-19 pandemic" External link

finanznachrichten-en Thursday, April 16, 2020 8:22:00 PM EAT

Matthieu Frechin said : “2019 featured growth in our Essentials products throughout our strategic regions and our Brazilian acquisition opened the door for us to build a big presence in the world’s third largest animal health market. We also made great strides in R&D that included launching or extending new products. That said, we took on board non-recurring costs that hit our bottom line. Our February 2020 announcement that we will acquire* a leading parasiticide product family opens up new opportunities. Lastly, regarding the current health crisis, I would like to salute the great work of our people who have all met their public health and ongoing care duties” External link

4-traders Thursday, March 26, 2020 10:54:00 AM EAT

Matthieu Frechin said : "We achieved a solid second semester and our annual performance is the result of our focused strategy and the acquisition in Brazil. This is reflected in the continued growth in Essentials sales across all strategic territories. The integration of Clarion in Brazil is progressing according to plan, while we continue to work on reorganizing our production facilities in Europe. We therefore look forward to 2020 with confidence in our plans to invest and secure sustainable long-term growth for our Group" External link

finanznachrichten-en Thursday, January 23, 2020 8:04:00 PM EAT

Matthieu Frechin déclaré : "Nous demeurons confiants pour la fin de l'exercice 2019 et restons actifs dans l'étude de dossiers de croissance externe" External link

capital-FR Thursday, October 17, 2019 5:41:00 PM EAT

Matthieu Frechin déclaré : "Nous demeurons confiants pour la fin de l'exercice 2019 et restons actifs dans l'étude de dossiers de croissance externe" External link

capital-FR Wednesday, October 16, 2019 7:28:00 PM EAT

Matthieu Frechin said : "We are delighted to have signed this agreement, which is fully in line with our In Motion strategic plan. Brazil is the third largest animal health market in the world and this acquisition will help further our plans to strengthen our foothold on this market" External link

finanznachrichten-en Thursday, April 4, 2019 9:23:00 AM EAT

Matthieu Frechin said : “We are delighted to have signed this agreement, which is fully in line with our In Motion strategic plan. Brazil is the third largest animal health market in the world and this acquisition will help further our plans to strengthen our foothold on this market” External link

4-traders Thursday, April 4, 2019 9:19:00 AM EAT

Matthieu Frechin said : “We are delighted to have signed this agreement, which is fully in line with our In Motion strategic plan. Brazil is the third largest animal health market in the world and this acquisition will help further our plans to strengthen our foothold on this market” External link

businesswire Thursday, April 4, 2019 9:11:00 AM EAT

Matthieu Frechin said : "This initial agreement demonstrates our commitment to the biotechnology sector. This investment is in keeping with our innovation strategy aimed at providing our vet customers with solutions for diseases where treatment is still lacking. PAT's ground-breaking technology can be adapted to the animal health sector, particularly in the area of monoclonal antibodies. PAT works on molecules of natural origin that are a potential alternative source of active ingredients for our future drugs" External link

finanznachrichten-en Monday, November 13, 2017 10:19:00 PM EAT



Key Titles and Phrases Count Lang Last Seen
directeur général70.00%FR01/26/201726/01/2017
ceo20.00%EN10/18/201618/10/2016
vétoquinol group ceo10.00%EN12/16/201316/12/2013
Names Lang Count
Matthieu FrechinFR66.67%
Matthieu FrechinEN33.33%


<<10<12345678910>>>10
<<10<12345678910>>>10

Tools

Load latest edition

Thursday, June 4, 2020

1:42:00 PM EAT


Quotes... Explore Relations


EMM Visual Explorer